Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Espinal

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Tuberculosis (Edinburgh, Scotland)|May 22, 2003
The global situation of MDR-TBMarcos A Espinal
Lancet Regional Health. Americas|April 25, 2023
The Pan American Health Organization: 120 years in the Americas hemisphereMarcos A Espinal
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 23, 2003
Time to abandon the standard retreatment regimen with first-line drugs for failures of standard treatmentMarcos A Espinal
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 18, 2008
The Stop TB Partnership and the role of The UnionMarcos A Espinal
Lancet (London, England)|February 2, 2012
WHO's relationship with the Stop TB PartnershipMarcos A Espinal
Lancet (London, England)|April 7, 2005
Can DOTS control multidrug-resistant tuberculosis?Marcos A Espinal, Christopher Dye
Proceedings. Biological Sciences|July 19, 2002
Will tuberculosis become resistant to all antibiotics?C Dye, M A Espinal
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 14, 2004
Eliminating tuberculosis: the time has come for business 'unusual'Marcos A Espinal, Satyajit Sarkar
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1984
Indirect ELISA test for malaria in blood donorsC A Espinal, P O de Morales
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 5, 2002
Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?R Gupta, M C Raviglione, M A Espinal
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Tuberculosis (Edinburgh, Scotland)|May 22, 2003
The global situation of MDR-TBMarcos A Espinal
Lancet Regional Health. Americas|April 25, 2023
The Pan American Health Organization: 120 years in the Americas hemisphereMarcos A Espinal
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 23, 2003
Time to abandon the standard retreatment regimen with first-line drugs for failures of standard treatmentMarcos A Espinal
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 18, 2008
The Stop TB Partnership and the role of The UnionMarcos A Espinal
Lancet (London, England)|February 2, 2012
WHO's relationship with the Stop TB PartnershipMarcos A Espinal
Lancet (London, England)|April 7, 2005
Can DOTS control multidrug-resistant tuberculosis?Marcos A Espinal, Christopher Dye
Proceedings. Biological Sciences|July 19, 2002
Will tuberculosis become resistant to all antibiotics?C Dye, M A Espinal
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 14, 2004
Eliminating tuberculosis: the time has come for business 'unusual'Marcos A Espinal, Satyajit Sarkar
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1984
Indirect ELISA test for malaria in blood donorsC A Espinal, P O de Morales
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 5, 2002
Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?R Gupta, M C Raviglione, M A Espinal
Pageof 9